WANTED – Dead or alive: Myotubularins, a large disease-associated protein family

Advances in Biological Regulation

Volumn 63, Issue , 2017, Pages 49-58

  Raess, Matthieu A ^a,b,c,d   Friant, Sylvie ^d   Cowling, Belinda S ^a,b,c,d   Laporte, Jocelyn ^a,b,c,d  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b INSERM   (France)

^c CNRS   (France)

^d UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Congenital myopathy; GTEx database; Myotubular myopathy; Myotubularin; Neuropathy; Sbf1

Indexed keywords

ISOPROTEIN; MESSENGER RNA; MYOTUBULARIN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE; PHOSPHATIDYLINOSITOL 3,5-DIPHOSPHATE; POLYPHOSPHOINOSITIDE; PROTEIN BINDING;

CHEMISTRY; GENE EXPRESSION; GENETICS; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; METABOLISM; MOLECULAR MODEL; MYOPATHY; NEOPLASM; OBESITY; PATHOLOGY; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN SECONDARY STRUCTURE; SIGNAL TRANSDUCTION;

CHARCOT-MARIE-TOOTH DISEASE; GENE EXPRESSION; HUMANS; MODELS, MOLECULAR; MYOPATHIES, STRUCTURAL, CONGENITAL; NEOPLASMS; OBESITY; PHOSPHATIDYLINOSITOL PHOSPHATES; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPPING; PROTEIN ISOFORMS; PROTEIN STRUCTURE, SECONDARY; PROTEIN TYROSINE PHOSPHATASES, NON-RECEPTOR; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84995799499     PISSN: 22124926     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.jbior.2016.09.001     Document Type: Review

References (75)

1. Agrawal, P.B., Pierson, C.R., Joshi, M., Liu, X., Ravenscroft, G., Moghadaszadeh, B., Talabere, T., Viola, M., Swanson, L.C., Haliloglu, G., Talim, B., Yau, K.S., Allcock, R.J., Laing, N.G., Perrella, M.A., Beggs, A.H., SPEG interacts with myotubularin, and its deficiency causes centronuclear myopathy with dilated cardiomyopathy. Am. J. Hum. Genet. 95:2 (2014), 218–226.
2. Alonso, A., Sasin, J., Bottini, N., Friedberg, I., Friedberg, I., Osterman, A., Godzik, A., Hunter, T., Dixon, J.E., Mustelin, T., Protein tyrosine phosphatases in the human genome. Cell 117:6 (2004), 699–711.
3. Amoasii, L., Bertazzi, D.L., Tronchere, H., Hnia, K., Chicanne, G., Rinaldi, B., Cowling, B.S., Ferry, A., Klaholz, B., Payrastre, B., Laporte, J., Friant, S., Phosphatase-dead myotubularin ameliorates X-linked centronuclear myopathy phenotypes in mice. PLoS Genet., 8(10), 2012, e1002965.
4. Azzedine, H., Bolino, A., Taieb, T., Birouk, N., Di Duca, M., Bouhouche, A., Benamou, S., Mrabet, A., Hammadouche, T., Chkili, T., Gouider, R., Ravazzolo, R., Brice, A., Laporte, J., LeGuern, E., Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of charcot-marie-tooth disease associated with early-onset glaucoma. Am. J. Hum. Genet. 72:5 (2003), 1141–1153.
5. Barr, F.A., Review series: Rab GTPases and membrane identity: causal or inconsequential?. J. Cell Biol. 202:2 (2013), 191–199.
6. Begley, M.J., Dixon, J.E., The structure and regulation of myotubularin phosphatases. Curr. Opin. Struct. Biol. 15:6 (2005), 614–620.
7. Begley, M.J., Taylor, G.S., Brock, M.A., Ghosh, P., Woods, V.L., Dixon, J.E., Molecular basis for substrate recognition by MTMR2, a myotubularin family phosphoinositide phosphatase. Proc. Natl. Acad. Sci. U. S. A. 103:4 (2006), 927–932.
8. Begley, M.J., Taylor, G.S., Kim, S.A., Veine, D.M., Dixon, J.E., Stuckey, J.A., Crystal structure of a phosphoinositide phosphatase, MTMR2: insights into myotubular myopathy and Charcot-Marie-Tooth syndrome. Mol. Cell 12:6 (2003), 1391–1402.
9. Berger, P., Niemann, A., Suter, U., Schwann cells and the pathogenesis of inherited motor and sensory neuropathies (Charcot-Marie-Tooth disease). Glia 54:4 (2006), 243–257.
10. Berger, P., Schaffitzel, C., Berger, I., Ban, N., Suter, U., Membrane association of myotubularin-related protein 2 is mediated by a pleckstrin homology-GRAM domain and a coiled-coil dimerization module. Proc. Natl. Acad. Sci. U. S. A. 100:21 (2003), 12177–12182.
11. Berggard, T., Arrigoni, G., Olsson, O., Fex, M., Linse, S., James, P., 140 mouse brain proteins identified by Ca2+-calmodulin affinity chromatography and tandem mass spectrometry. J. Proteome Res. 5:3 (2006), 669–687.
12. Blondeau, F., Laporte, J., Bodin, S., Superti-Furga, G., Payrastre, B., Mandel, J.L., Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway. Hum. Mol. Genet. 9:15 (2000), 2223–2229.
13. Bolino, A., Bolis, A., Previtali, S.C., Dina, G., Bussini, S., Dati, G., Amadio, S., Del Carro, U., Mruk, D.D., Feltri, M.L., Cheng, C.Y., Quattrini, A., Wrabetz, L., Disruption of Mtmr2 produces CMT4B1-like neuropathy with myelin outfolding and impaired spermatogenesis. J. Cell Biol. 167:4 (2004), 711–721.
14. Bolino, A., Lonie, L.J., Zimmer, M., Boerkoel, C.F., Takashima, H., Monaco, A.P., Lupski, J.R., Denaturing high-performance liquid chromatography of the myotubularin-related 2 gene (MTMR2) in unrelated patients with Charcot-Marie-Tooth disease suggests a low frequency of mutation in inherited neuropathy. Neurogenetics 3:2 (2001), 107–109.
15. Bolino, A., Muglia, M., Conforti, F.L., LeGuern, E., Salih, M.A., Georgiou, D.M., Christodoulou, K., Hausmanowa-Petrusewicz, I., Mandich, P., Schenone, A., Gambardella, A., Bono, F., Quattrone, A., Devoto, M., Monaco, A.P., Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat. Genet. 25:1 (2000), 17–19.
16. Bong, S.M., Son, K.B., Yang, S.W., Park, J.W., Cho, J.W., Kim, K.T., Kim, H., Kim, S.J., Kim, Y.J., Lee, B.I., Crystal structure of human myotubularin-related protein 1 provides insight into the structural basis of substrate specificity. PLoS One, 11(3), 2016, e0152611.
17. Buj-Bello, A., Furling, D., Tronchere, H., Laporte, J., Lerouge, T., Butler-Browne, G.S., Mandel, J.L., Muscle-specific alternative splicing of myotubularin-related 1 gene is impaired in DM1 muscle cells. Hum. Mol. Genet. 11:19 (2002), 2297–2307.
18. Bulley, S.J., Clarke, J.H., Droubi, A., Giudici, M.L., Irvine, R.F., Exploring phosphatidylinositol 5-phosphate 4-kinase function. Adv. Biol. Regul. 57 (2015), 193–202.
19. Cao, C., Laporte, J., Backer, J.M., Wandinger-Ness, A., Stein, M.P., Myotubularin lipid phosphatase binds the hVPS15/hVPS34 lipid kinase complex on endosomes. Traffic 8:8 (2007), 1052–1067.
20. Choudhury, P., Srivastava, S., Li, Z., Ko, K., Albaqumi, M., Narayan, K., Coetzee, W.A., Lemmon, M.A., Skolnik, E.Y., Specificity of the myotubularin family of phosphatidylinositol-3-phosphatase is determined by the PH/GRAM domain. J. Biol. Chem. 281:42 (2006), 31762–31769.
21. Cui, X., De Vivo, I., Slany, R., Miyamoto, A., Firestein, R., Cleary, M.L., Association of SET domain and myotubularin-related proteins modulates growth control. Nat. Genet. 18:4 (1998), 331–337.
22. Di Paolo, G., De Camilli, P., Phosphoinositides in cell regulation and membrane dynamics. Nature 443:7112 (2006), 651–657.
23. Doerks, T., Strauss, M., Brendel, M., Bork, P., GRAM, a novel domain in glucosyltransferases, myotubularins and other putative membrane-associated proteins. Trends Biochem. Sci. 25:10 (2000), 483–485.
24. Fabre, S., Reynaud, C., Jalinot, P., Identification of functional PDZ domain binding sites in several human proteins. Mol. Biol. Rep. 27:4 (2000), 217–224.
25. Firestein, R., Cui, X., Huie, P., Cleary, M.L., Set domain-dependent regulation of transcriptional silencing and growth control by SUV39H1, a mammalian ortholog of Drosophila Su(var)3-9. Mol. Cell Biol. 20:13 (2000), 4900–4909.
26. Firestein, R., Nagy, P.L., Daly, M., Huie, P., Conti, M., Cleary, M.L., Male infertility, impaired spermatogenesis, and azoospermia in mice deficient for the pseudophosphatase Sbf1. J. Clin. Invest. 109:9 (2002), 1165–1172.
27. Giudici, M.L., Clarke, J.H., Irvine, R.F., Phosphatidylinositol 5-phosphate 4-kinase gamma (PI5P4Kgamma), a lipid signalling enigma. Adv. Biol. Regul. 61 (2016), 47–50.
28. Goldfarb, L.G., Park, K.Y., Cervenakova, L., Gorokhova, S., Lee, H.S., Vasconcelos, O., Nagle, J.W., Semino-Mora, C., Sivakumar, K., Dalakas, M.C., Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nat. Genet. 19:4 (1998), 402–403.
29. Gozani, O., Karuman, P., Jones, D.R., Ivanov, D., Cha, J., Lugovskoy, A.A., Baird, C.L., Zhu, H., Field, S.J., Lessnick, S.L., Villasenor, J., Mehrotra, B., Chen, J., Rao, V.R., Brugge, J.S., Ferguson, C.G., Payrastre, B., Myszka, D.G., Cantley, L.C., Wagner, G., Divecha, N., Prestwich, G.D., Yuan, J., The PHD finger of the chromatin-associated protein ING2 functions as a nuclear phosphoinositide receptor. Cell 114 (2003), 99–111.
30. Gupta, V.A., Hnia, K., Smith, L.L., Gundry, S.R., McIntire, J.E., Shimazu, J., Bass, J.R., Talbot, E.A., Amoasii, L., Goldman, N.E., Laporte, J., Beggs, A.H., Loss of catalytically inactive lipid phosphatase myotubularin-related protein 12 impairs myotubularin stability and promotes centronuclear myopathy in zebrafish. PLoS Genet., 9(6), 2013, e1003583.
31. Hnia, K., Tronchere, H., Tomczak, K.K., Amoasii, L., Schultz, P., Beggs, A.H., Payrastre, B., Mandel, J.L., Laporte, J., Myotubularin controls desmin intermediate filament architecture and mitochondrial dynamics in human and mouse skeletal muscle. J. Clin. Invest. 121:1 (2011), 70–85.
32. Hotta, K., Kitamoto, T., Kitamoto, A., Mizusawa, S., Matsuo, T., Nakata, Y., Kamohara, S., Miyatake, N., Kotani, K., Komatsu, R., Itoh, N., Mineo, I., Wada, J., Yoneda, M., Nakajima, A., Funahashi, T., Miyazaki, S., Tokunaga, K., Masuzaki, H., Ueno, T., Hamaguchi, K., Tanaka, K., Yamada, K., Hanafusa, T., Oikawa, S., Yoshimatsu, H., Sakata, T., Matsuzawa, Y., Nakao, K., Sekine, A., Association of variations in the FTO, SCG3 and MTMR9 genes with metabolic syndrome in a Japanese population. J. Hum. Genet. 56:9 (2011), 647–651.
33. Hu, J., Prinz, W.A., Rapoport, T.A., Weaving the web of ER tubules. Cell 147:6 (2011), 1226–1231.
34. Itoh, T., Takenawa, T., Phosphoinositide-binding domains: functional units for temporal and spatial regulation of intracellular signalling. Cell. Signal. 14:9 (2002), 733–743.
35. Jean, S., Cox, S., Schmidt, E.J., Robinson, F.L., Kiger, A., Sbf/MTMR13 coordinates PI(3)P and Rab21 regulation in endocytic control of cellular remodeling. Mol. Biol. Cell 23:14 (2012), 2723–2740.
36. Jungbluth, H., Wallgren-Pettersson, C., Laporte, J., Centronuclear (myotubular) myopathy. Orphanet J. Rare Dis., 3, 2008, 26.
37. Keune, W.J., Jones, D.R., Divecha, N., PtdIns5P and Pin1 in oxidative stress signaling. Adv. Biol. Regul. 53:2 (2013), 179–189.
38. Kim, S.A., Vacratsis, P.O., Firestein, R., Cleary, M.L., Dixon, J.E., Regulation of myotubularin-related (MTMR)2 phosphatidylinositol phosphatase by MTMR5, a catalytically inactive phosphatase. Proc. Natl. Acad. Sci. U. S. A. 100:8 (2003), 4492–4497.
39. Laporte, J., Bedez, F., Bolino, A., Mandel, J.L., Myotubularins, a large disease-associated family of cooperating catalytically active and inactive phosphoinositides phosphatases. Hum. Mol. Genet. 12:Spec No 2 (2003), R285–R292.
40. Laporte, J., Hu, L.J., Kretz, C., Mandel, J.L., Kioschis, P., Coy, J.F., Klauck, S.M., Poustka, A., Dahl, N., A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat. Genet. 13:2 (1996), 175–182.
41. Lecompte, O., Poch, O., Laporte, J., PtdIns5P regulation through evolution: roles in membrane trafficking?. Trends Biochem. Sci. 33:10 (2008), 453–460.
42. Li, X., Tran, K.M., Aziz, K.E., Sorokin, A.V., Chen, J., Wang, W., Defining the protein-protein interaction network of the human protein tyrosine phosphatase family. Mol. Cell Proteomics 15:9 (2016), 3030–3044.
43. Lorenzo, O., Urbe, S., Clague, M.J., Systematic analysis of myotubularins: heteromeric interactions, subcellular localisation and endosome related functions. J. Cell Sci. 119:Pt 14 (2006), 2953–2959.
44. Mersiyanova, I.V., Perepelov, A.V., Polyakov, A.V., Sitnikov, V.F., Dadali, E.L., Oparin, R.B., Petrin, A.N., Evgrafov, O.V., A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am. J. Hum. Genet. 67:1 (2000), 37–46.
45. Mochizuki, Y., Majerus, P.W., Characterization of myotubularin-related protein 7 and its binding partner, myotubularin-related protein 9. Proc. Natl. Acad. Sci. U. S. A. 100:17 (2003), 9768–9773.
46. Mochizuki, Y., Ohashi, R., Kawamura, T., Iwanari, H., Kodama, T., Naito, M., Hamakubo, T., Phosphatidylinositol 3-phosphatase myotubularin-related protein 6 (MTMR6) is regulated by small GTPase Rab1B in the early secretory and autophagic pathways. J. Biol. Chem. 288:2 (2013), 1009–1021.
47. Nandurkar, H.H., Caldwell, K.K., Whisstock, J.C., Layton, M.J., Gaudet, E.A., Norris, F.A., Majerus, P.W., Mitchell, C.A., Characterization of an adapter subunit to a phosphatidylinositol (3)P 3- phosphatase: identification of a myotubularin-related protein lacking catalytic activity. Proc. Natl. Acad. Sci. U. S. A. 98:17 (2001), 9499–9504.
48. Nandurkar, H.H., Huysmans, R., The myotubularin family: novel phosphoinositide regulators. IUBMB Life 53:1 (2002), 37–43.
49. Nandurkar, H.H., Layton, M., Laporte, J., Selan, C., Corcoran, L., Caldwell, K.K., Mochizuki, Y., Majerus, P.W., Mitchell, C.A., Identification of myotubularin as the lipid phosphatase catalytic subunit associated with the 3-phosphatase adapter protein, 3-PAP. Proc. Natl. Acad. Sci. U. S. A. 100:15 (2003), 8660–8665.
50. Nicot, A.S., Laporte, J., Endosomal phosphoinositides and human diseases. Traffic 9:8 (2008), 1240–1249.
51. Plant, P.J., Correa, J., Goldenberg, N., Bain, J., Batt, J., The inositol phosphatase MTMR4 is a novel target of the ubiquitin ligase Nedd4. Biochem. J. 419:1 (2009), 57–63.
52. Previtali, S.C., Zerega, B., Sherman, D.L., Brophy, P.J., Dina, G., King, R.H.M., Salih, M.M., Feltri, L., Quattrini, A., Ravazzolo, R., Wrabetz, L., Monaco, A.P., Bolino, A., Myotubularin-related 2 protein phosphatase and neurofilament light chain protein, both mutated in CMT neuropathies, interact in peripheral nerve. Hum. Mol. Genet. 12:14 (2003), 1713–1723.
53. Ramel, D., Lagarrigue, F., Pons, V., Mounier, J., Dupuis-Coronas, S., Chicanne, G., Sansonetti, P.J., Gaits-Iacovoni, F., Tronchere, H., Payrastre, B., Shigella flexneri infection generates the lipid PI5P to alter endocytosis and prevent termination of EGFR signaling. Sci. Signal, 4(191), 2011, ra61.
54. Robinson, F.L., Dixon, J.E., Myotubularin phosphatases: policing 3-phosphoinositides. Trends Cell Biol. 16:8 (2006), 403–412.
55. Royer, B., Hnia, K., Gavriilidis, C., Tronchere, H., Tosch, V., Laporte, J., The myotubularin-amphiphysin 2 complex in membrane tubulation and centronuclear myopathies. EMBO Rep. 14:10 (2013), 907–915.
56. Rual, J.F., Venkatesan, K., Hao, T., Hirozane-Kishikawa, T., Dricot, A., Li, N., Berriz, G.F., Gibbons, F.D., Dreze, M., Ayivi-Guedehoussou, N., Klitgord, N., Simon, C., Boxem, M., Milstein, S., Rosenberg, J., Goldberg, D.S., Zhang, L.V., Wong, S.L., Franklin, G., Li, S., Albala, J.S., Lim, J., Fraughton, C., Llamosas, E., Cevik, S., Bex, C., Lamesch, P., Sikorski, R.S., Vandenhaute, J., Zoghbi, H.Y., Smolyar, A., Bosak, S., Sequerra, R., Doucette-Stamm, L., Cusick, M.E., Hill, D.E., Roth, F.P., Vidal, M., Towards a proteome-scale map of the human protein-protein interaction network. Nature 437:7062 (2005), 1173–1178.
57. Sabha, N., Volpatti, J.R., Gonorazky, H., Reifler, A., Davidson, A.E., Li, X., Eltayeb, N.M., Dall'Armi, C., Di Paolo, G., Brooks, S.V., Buj-Bello, A., Feldman, E.L., Dowling, J.J., PIK3C2B inhibition improves function and prolongs survival in myotubular myopathy animal models. J. Clin. Invest. 126:9 (2016), 3613–3625.
58. Sanchez-Juan, P., Bishop, M.T., Aulchenko, Y.S., Brandel, J.P., Rivadeneira, F., Struchalin, M., Lambert, J.C., Amouyel, P., Combarros, O., Sainz, J., Carracedo, A., Uitterlinden, A.G., Hofman, A., Zerr, I., Kretzschmar, H.A., Laplanche, J.L., Knight, R.S., Will, R.G., van Duijn, C.M., Genome-wide study links MTMR7 gene to variant Creutzfeldt-Jakob risk. Neurobiol. Aging, 33(7), 2012 1487 e1421–1488.
59. Schaletzky, J., Dove, S.K., Short, B., Lorenzo, O., Clague, M.J., Barr, F.A., Phosphatidylinositol-5-phosphate activation and conserved substrate specificity of the myotubularin phosphatidylinositol 3-phosphatases. Curr. Biol. 13:6 (2003), 504–509.
60. Senderek, J., Bergmann, C., Weber, S., Ketelsen, U.P., Schorle, H., Rudnik-Schoneborn, S., Buttner, R., Buchheim, E., Zerres, K., Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15. Hum. Mol. Genet. 12:3 (2003), 349–356.
61. Song, H.O., Lee, J., Ji, Y.J., Dwivedi, M., Cho, J.H., Park, B.J., Ahnn, J., Calcineurin regulates coelomocyte endocytosis via DYN-1 and CUP-4 in Caenorhabditis elegans. Mol. Cells 30:3 (2010), 255–262.
62. Srivastava, S., Li, Z., Lin, L., Liu, G., Ko, K., Coetzee, W.A., Skolnik, E.Y., The phosphatidylinositol 3-phosphate phosphatase myotubularin- related protein 6 (MTMR6) is a negative regulator of the Ca2+-activated K+ channel KCa3.1. Mol. Cell Biol. 25:9 (2005), 3630–3638.
63. Staiano, L., De Leo, M.G., Persico, M., De Matteis, M.A., Mendelian disorders of PI metabolizing enzymes. Biochim. Biophys. Acta 1851:6 (2015), 867–881.
64. Taylor, G.S., Maehama, T., Dixon, J.E., Inaugural article: myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate. Proc. Natl. Acad. Sci. U. S. A. 97:16 (2000), 8910–8915.
65. Tosch, V., Rohde, H.M., Tronchere, H., Zanoteli, E., Monroy, N., Kretz, C., Dondaine, N., Payrastre, B., Mandel, J.L., Laporte, J., A novel PtdIns3P and PtdIns(3,5)P2 phosphatase with an inactivating variant in centronuclear myopathy. Hum. Mol. Genet. 15:21 (2006), 3098–3106.
66. Tronchere, H., Laporte, J., Pendaries, C., Chaussade, C., Liaubet, L., Pirola, L., Mandel, J.L., Payrastre, B., Production of phosphatidylinositol 5-phosphate by the phosphoinositide 3-phosphatase myotubularin in mammalian cells. J. Biol. Chem. 279:8 (2004), 7304–7312.
67. Tsujita, K., Itoh, T., Ijuin, T., Yamamoto, A., Shisheva, A., Laporte, J., Takenawa, T., Myotubularin regulates the function of the late endosome through the gram domain-phosphatidylinositol 3,5-bisphosphate interaction. J. Biol. Chem. 279:14 (2004), 13817–13824.
68. Velichkova, M., Juan, J., Kadandale, P., Jean, S., Ribeiro, I., Raman, V., Stefan, C., Kiger, A.A., Drosophila Mtm and class II PI3K coregulate a PI(3)P pool with cortical and endolysosomal functions. J. Cell Biol. 190:3 (2010), 407–425.
69. Walker, D.M., Urbe, S., Dove, S.K., Tenza, D., Raposo, G., Clague, M.J., Characterization of MTMR3. an inositol lipid 3-phosphatase with novel substrate specificity. Curr. Biol. 11:20 (2001), 1600–1605.
70. Weidner, P., Sohn, M., Gutting, T., Friedrich, T., Gaiser, T., Magdeburg, J., Kienle, P., Ruh, H., Hopf, C., Behrens, H.M., Rocken, C., Hanoch, T., Seger, R., Ebert, M.P., Burgermeister, E., Myotubularin-related protein 7 inhibits insulin signaling in colorectal cancer. Oncotarget 7:31 (2016), 50490–50506.
71. Yoshimura, S., Gerondopoulos, A., Linford, A., Rigden, D.J., Barr, F.A., Family-wide characterization of the DENN domain Rab GDP-GTP exchange factors. J. Cell Biol. 191:2 (2010), 367–381.
72. Yu, J., He, X., Chen, Y.G., Hao, Y., Yang, S., Wang, L., Pan, L., Tang, H., Myotubularin-related protein 4 (MTMR4) attenuates BMP/Dpp signaling by dephosphorylation of Smad proteins. J. Biol. Chem. 288:1 (2013), 79–88.
73. Zhang, J., Wong, C.H., Xia, W., Mruk, D.D., Lee, N.P., Lee, W.M., Cheng, C.Y., Regulation of Sertoli-germ cell adherens junction dynamics via changes in protein-protein interactions of the N-cadherin-beta-catenin protein complex which are possibly mediated by c-Src and myotubularin-related protein 2: an in vivo study using an androgen suppression model. Endocrinology 146:3 (2005), 1268–1284.
74. Zhang, Z.Y., Maclean, D., McNamara, D.J., Sawyer, T.K., Dixon, J.E., Protein tyrosine phosphatase substrate specificity: size and phosphotyrosine positioning requirements in peptide substrates. Biochemistry 33:8 (1994), 2285–2290.
75. Zou, W., Lu, Q., Zhao, D., Li, W., Mapes, J., Xie, Y., Wang, X., Caenorhabditis elegans myotubularin MTM-1 negatively regulates the engulfment of apoptotic cells. PLoS Genet., 5(10), 2009, e1000679.